Donald Trump, the U.S. President, finalized a trade agreement with Japan. The deal reduces tariffs on auto imports. Japan will invest $550 billion in the U.S. Japan will also purchase 100 Boeing planes. Defense spending with U.S. firms will increase. Japan s Nikkei stock index saw a rise.

Indian Railway Finance Corporation (IRFC) reported its highest-ever quarterly net profit of Rs 1,746 crore and total income in Q1FY26. Revenue from operations increased to Rs 6,915 crore, with net interest margin improving to 1.53%. The company s net worth reached a record high of Rs 54,424 crore, maintaining zero non-performing assets.

Kaytex Fabrics is set to make its debut on the stock market with an IPO scheduled for July 29. Shares are priced between Rs 171 and Rs 180 each, with the company aiming to raise around Rs 70 crore.

Wall Street opened higher on Wednesday after President Donald Trump struck a trade deal with Japan, shoring up expectations of further agreements ahead of the fast-approaching August 1 deadline.

Gold prices have surged past ₹1 lakh per 10 g, driven by global demand, trade uncertainties, and a weak rupee, pressuring festive jewellery sales and boosting investor interest in lightweight, lower-karat and investment-grade formats.

Wall Street is witnessing a resurgence of meme stocks, with companies like Krispy Kreme, GoPro, and Beyond Meat experiencing significant surges driven by social media hype. These companies, many struggling with profitability, are attracting investors betting on continued momentum.

Sri Lotus Developers and Realty is set to launch its IPO next Wednesday, having allotted equity shares to prominent figures like Shah Rukh Khan, Amitabh Bachchan, the Roshan family, and Ashish Kacholia at Rs 150 apiece. The company aims to raise Rs 792 crore through this IPO, building on a previous private placement that included other Bollywood celebrities.

Bajaj Housing Finance posted a 21% YoY rise in Q1 net profit to ₹583 crore, with steady margins and healthy asset quality. AUM rose 24% to Rs 1.2 lakh crore despite competitive pricing and real estate demand moderation.

Shares of Sarepta Therapeutics fell nearly 7% on Tuesday after the company agreed to comply with the U.S. health regulator s request to pause all shipments of its gene therapy Elevidys in the United States.